ALK translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers

Journal of Thoracic Oncology

Volumn 6, Issue 8, 2011, Pages 1439-1440

  Klempner, Samuel J ^a   Cohen, David W ^b   Costa, Daniel B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CRIZOTINIB; CYTOKERATIN; THYROID TRANSCRIPTION FACTOR 1;

ADULT; CANCER CLASSIFICATION; CANCER STAGING; CASE REPORT; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOLOGY; LUNG ADENOCARCINOMA; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; NOTE; PRIORITY JOURNAL;

EID: 80051775807     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182217c01     Document Type: Article

References (5)

1. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285.
2. Solomon B, Varella-Garcia M, Camidge DR. ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer. J Thorac Oncol 2009;4:1450-1454.
3. Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4- ALK. J Clin Oncol 2009;27:4247-4253.
4. Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363:1693-1703.
5. Paik JH, Choe G, Kim H, et al. Screening of anaplastic lymphoma kinaserearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. J Thorac Oncol 2011;6:466-472.